Breaking News, Collaborations & Alliances

ATMI Invests in Medinstill

Focuses on sterile fill technology

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

ATMI, Inc., a provider of single-use bioprocess solutions, has invested in sterile connector and sterile fill technology developed by Medical Instill Technologies (Medinstill), a company dedicated to developing solutions for the transfer and packaging of high purity fluids at unmatched safety levels. The investments focus on the INTACT family of products developed by Medinstill. These technologies will be deployed in sterile filling, sterile multiple-dose dispensing, sterile transfer, and packa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters